Literature DB >> 24126016

Capacity of HSYA to inhibit nitrotyrosine formation induced by focal ischemic brain injury.

Li Sun1, Li Yang, Ying Fu, Jing Han, Yanwei Xu, Hao Liang, Yan Cheng.   

Abstract

Peroxynitrite-mediated protein tyrosine nitration represents a crucial pathogenic mechanism of stroke. Hydroxysafflor yellow A (HSYA) is the most important active component of the safflower plant. Here we assess the neuroprotective efficacy of HSYA and investigate the mechanism through anti-nitrative pathway. Rats were subjected to 60-min ischemia followed by reperfusion. HSYA (2.5-10mg/kg) was injected at 1h after ischemia onset. Other groups received HSYA (10mg/kg) treatment at 3-9h after onset. Infarct volume, brain edema, and neurological score were evaluated at 24h after ischemia. Nitrotyrosine and inducible NO synthase (iNOS) expression, as well as NO level (nitrate/nitrite) in ischemic cortex was examined within 24h after ischemia. The ability of HSYA to scavenge peroxynitrite was evaluated in vitro. Infarct volume was significantly decreased by HSYA (P<0.05), with a therapeutic window of 3h after ischemia at dose of 10mg/kg. HSYA treatment also reduced brain edema and improved neurological score (P<0.05). Nitrotyrosine formation was dose- and time-dependently inhibited by HSYA. The time window of HSYA in decreasing protein tyrosine nitration paralleled its action in infarct volume. HSYA also greatly reduced iNOS expression and NO content at 24h after ischemia, suggesting prevention of peroxynitrite generation from iNOS. In vitro, HSYA blocked authentic peroxynitrite-induced tyrosine nitration in bovine serum albumin and primary cortical neurons. Collectively, our results indicated that post-ischemic HSYA treatment attenuates brain ischemic injury which is at least partially due to reducing nitrotyrosine formation, possibly by the combined mechanism of its peroxynitrite scavenging ability and its reduction in iNOS production.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-NT; 3-nitrotyrosine; AG; BSA; Cerebral ischemia; HSYA; Hydroxysafflor yellow A; MCA; MCAO; NO; Nitric oxide synthase; Nitrotyrosine; ONOO(−); Peroxynitrite; aminoguanidine; bovine serum albumin; hydroxysafflor yellow A; iNOS; inducible NO synthase; middle cerebral artery; middle cerebral artery occlusion; nitric oxide; peroxynitrite

Mesh:

Substances:

Year:  2013        PMID: 24126016     DOI: 10.1016/j.niox.2013.10.002

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  8 in total

1.  12/15-Lipoxygenase metabolites of arachidonic acid activate PPARγ: a possible neuroprotective effect in ischemic brain.

Authors:  Li Sun; Yan-Wei Xu; Jing Han; Hao Liang; Ning Wang; Yan Cheng
Journal:  J Lipid Res       Date:  2015-01-20       Impact factor: 5.922

2.  Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes.

Authors:  Mohammed Abdelsaid; Roshini Prakash; Weiguo Li; Maha Coucha; Sherif Hafez; Maribeth H Johnson; Susan C Fagan; Adviye Ergul
Journal:  Diabetes       Date:  2014-12-18       Impact factor: 9.461

3.  HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.

Authors:  Jun-Peng Pei; Li-Hong Fan; Kai Nan; Jia Li; Xiao-Qian Dang; Kun-Zheng Wang
Journal:  J Neuroinflammation       Date:  2017-05-03       Impact factor: 8.322

4.  Hydroxysafflor Yellow A Shows Protection against PPARγ Inactivation in Nitrosative Neurons.

Authors:  Li Sun; Yan-Wei Xu; Jing Han; Chen Xiao; Shan-Shan Cao; Hao Liang; Yan Cheng
Journal:  Oxid Med Cell Longev       Date:  2018-10-16       Impact factor: 6.543

5.  Hydroxysafflor Yellow A (HSYA) Improves Learning and Memory in Cerebral Ischemia Reperfusion-Injured Rats via Recovering Synaptic Plasticity in the Hippocampus.

Authors:  Lu Yu; Yanhong Duan; Zheng Zhao; Wendi He; Ming Xia; Qiujuan Zhang; Xiaohua Cao
Journal:  Front Cell Neurosci       Date:  2018-10-18       Impact factor: 5.505

6.  Acorus tatarinowii Schott extract reduces cerebral edema caused by ischemia-reperfusion injury in rats: involvement in regulation of astrocytic NKCC1/AQP4 and JNK/iNOS-mediated signaling.

Authors:  Yu-Chen Lee; Shung-Te Kao; Chin-Yi Cheng
Journal:  BMC Complement Med Ther       Date:  2020-12-09

7.  Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study.

Authors:  Li Yu; Hao-Fang Wan; Chang Li; Jie-Hong Yang; Hui-Fen Zhou; Hai-Tong Wan; Yu He
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

Review 8.  Hydroxysafflor Yellow A: A Promising Therapeutic Agent for a Broad Spectrum of Diseases.

Authors:  Hui Ao; Wuwen Feng; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-25       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.